Akebia Therapeutics AKBA Balance Sheet (2013-2026)

NASDAQ AKBA
$0.89 -0.01 (-0.78%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Akebia Therapeutics Quarterly Balance Sheet

Periods 54 quarters
Latest Jun 2026

Akebia Therapeutics reported total assets of $349.66M and total liabilities of $324.64M for the quarter ended Jun 2026, up 1.2% year over year. This balance sheet covers 54 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
207.20M149.80M174.60M143.90M144.80M90.47M57.00M53.60M46.53M42.92M42.00M39.50M34.02M51.87M113.40M137.31M166.44M184.84M162.64M155.55M
Short-term InvestmentsInvestments (Current)
Cash & Current Investments
207.20M149.80M174.60M143.90M144.80M90.47M57.00M53.60M46.53M42.92M42.00M39.50M34.02M51.87M113.40M137.31M166.44M184.84M162.64M155.55M
Receivables - NetNet Receivables
49.69M51.58M65.36M82.00M23.27M40.28M18.73M19.57M22.59M39.29M26.62M29.77M32.17M34.37M61.54M130.80M66.22M47.03M62.54M53.51M
Receivables - OtherOther Receivables
24.86M23.40M28.29M66.18M7.48M2.68M0.42M0.53M0.48M3.33M2.69M1.83M1.82M2.01M1.57M7.41M3.06M2.58M1.66M5.37M
Receivables
74.55M74.98M93.64M148.18M30.75M42.97M19.15M20.10M23.07M42.62M29.31M31.59M33.99M36.38M63.10M138.21M69.28M49.62M64.20M58.88M
Inventory
33.69M36.63M41.10M40.23M45.24M21.57M20.41M20.91M18.44M15.69M25.53M23.87M20.49M16.24M19.73M16.71M18.64M15.61M13.00M13.02M
Prepaid Assets
39.50M33.14M24.12M42.13M28.94M32.86M24.70M24.40M22.04M20.24M18.83M18.96M13.44M11.35M9.14M7.83M7.03M5.47M5.30M7.48M
Current Assets
330.08M271.15M305.14M308.25M242.21M185.18M120.80M118.45M109.60M118.15M112.94M112.10M100.12M113.83M203.78M234.66M258.34M252.96M243.48M229.55M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
7.20M6.75M6.45M6.04M5.62M5.21M4.82M4.42M4.02M3.63M3.27M2.90M2.53M2.20M1.90M1.71M1.47M1.22M0.96M1.51M
Long-Term Investments
Goodwill
55.10M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M59.04M
Intangibles
117.14M108.13M99.12M90.11M81.09M72.08M63.07M54.06M45.05M36.04M27.03M18.02M9.01M
Goodwill & Intangibles
172.24M167.17M158.16M149.15M140.14M131.13M122.12M113.11M104.10M95.09M86.08M77.06M68.06M59.04M59.04M59.04M59.04M59.04M59.04M59.04M
Other Non-Current Assets
69.60M50.42M39.42M34.95M25.94M5.37M5.24M3.35M3.86M12.42M11.79M17.78M27.13M37.38M38.34M44.19M40.46M59.68M56.57M53.75M
Non-Current Assets
272.18M258.20M236.66M221.63M202.04M170.87M160.13M135.26M125.40M123.55M112.53M108.10M107.02M106.84M106.40M110.94M105.82M123.61M119.04M120.11M
Assets
602.27M529.35M541.80M529.88M444.25M356.05M280.93M253.71M235.00M241.70M225.48M220.20M207.14M220.67M310.19M345.60M364.15M376.56M362.52M349.66M
Liabilities
Current Liabilities
Accounts Payables
28.81M33.59M19.47M24.94M19.71M18.02M12.58M11.78M9.04M14.63M11.88M10.11M13.49M15.18M12.66M11.55M10.09M21.18M8.39M9.42M
Payables
28.81M33.59M19.47M24.94M19.71M18.02M12.58M11.78M9.04M14.63M11.88M10.11M13.49M15.18M12.66M11.55M10.09M21.18M8.39M9.42M
Accumulated Expenses
144.70M109.01M114.24M95.00M92.53M75.78M51.08M56.41M62.66M67.73M53.91M53.90M52.22M63.46M71.34M91.61M106.42M121.72M125.06M109.80M
Other Accumulated Expenses
Short term Debt
97.54M97.85M98.16M65.95M32.00M24.00M24.00M8.00M17.50M12.49M24.81M
Current Leases
Current Taxes
Current Deferred Revenue
15.69M20.91M10.44M5.05M1.26M3.74M0.69M43.30M1.24M5.53M3.88M2.68M4.50M6.17M
Total Current Liabilities
189.21M261.05M258.50M237.40M193.13M129.54M87.66M92.18M79.70M99.87M66.49M107.30M65.71M80.91M91.23M118.72M133.38M162.94M173.88M160.87M
Non-Current Liabilities
Capital Leases
Non-Current Debt
97.23M34.08M26.30M18.49M34.61M17.18M30.14M38.03M38.35M38.69M46.51M47.06M47.64M48.25M36.40M24.75M
Non-Current Deffered Revenue
27.96M21.47M65.36M43.30M43.30M43.30M43.30M43.30M43.30M43.30M43.30M
Preferred Stock Liabilities
Operating Leases
20.26M33.70M32.58M31.73M30.68M28.96M27.42M11.48M10.23M8.95M7.64M6.30M4.94M3.55M2.12M0.67M4.40M
Other Non-Current Liabilities
77.39M84.21M83.14M74.61M83.10M15.72M16.77M17.14M9.41M8.88M6.77M6.56M4.73M5.20M7.22M14.20M5.24M3.00M2.52M2.00M
Total Non-Current Liabilities
387.72M371.13M436.08M396.33M352.89M335.11M283.28M263.38M265.00M263.40M245.96M247.39M252.82M264.65M278.38M302.17M317.32M340.95M332.62M322.64M
Total Liabilities
465.12M455.34M519.22M470.94M435.99M350.82M300.05M280.52M274.42M272.29M252.74M253.95M257.54M269.86M285.60M316.37M322.56M343.95M335.14M324.64M
Shareholder's Equity
Total Debt
97.23M97.54M97.85M98.16M65.95M66.08M50.30M42.49M42.61M34.68M30.14M38.03M38.35M38.69M46.51M47.06M47.64M48.25M48.89M49.56M
Common Equity
137.15M74.01M22.58M58.94M8.26M5.23M-19.12M-26.80M-39.42M-30.58M-27.26M-33.75M-50.40M-49.19M24.58M29.22M41.59M32.61M27.38M25.02M
Liabilities and Shareholders Equity
602.27M529.35M541.80M529.88M444.25M356.05M280.93M253.71M235.00M241.70M225.48M220.20M207.14M220.67M310.19M345.60M364.15M376.56M362.52M349.66M
Treasury Shares
Retained Earnings
-1389.67M-1462.80M-1526.31M-1496.86M-1550.95M-1557.03M-1583.90M-1595.08M-1609.56M-1608.95M-1626.93M-1635.52M-1655.56M-1678.36M-1672.25M-1672.00M-1671.46M-1683.70M-1692.76M-1701.67M

Akebia Therapeutics Balance Sheet API

Pull Akebia Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AKBA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY